Clinuvel Pharmaceuticals buy Savour
Start price
20.03.19
/
50%
€16.90
Target price
07.12.19
-
Performance (%)
-1.89%
End price
07.12.19
€16.58
Summary
This prediction ended on 07.12.19 with a price of €16.58. With a performance of -1.89%, the BUY prediction by Savour finished with a loss. Dividends of €0.015 are taken into consideration when calculating the performance. Savour has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -3.426% | -3.426% | -6.209% | -53.700% |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % | 51,11 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % | 91,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % | 65,85 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % | 66,64 % |
Comments by Savour for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
Savour stimmt der Buy-Einschätzung von Maxi-Scalibusa zu
Savour stimmt am 20.03.2019 der Buy-Einschätzung von Maxi-Scalibusa mit dem Kursziel 19,5€ zu.
Überschrift: Highflyer
Stopped prediction by Savour for Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€17.85
22.12.19
22.12.19
-
11.07.20
11.07.20
-23.08%
11.07.20
11.07.20
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€16.60
07.12.19
07.12.19
-
22.12.19
22.12.19
7.53%
22.12.19
22.12.19